
Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumours
New results from early clinical trials of a drug that targets a cancer-causing mutation in…
New results from early clinical trials of a drug that targets a cancer-causing mutation in…
The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, Spain, led by Dr. Francesc…
Considered the “guardian of the genome,” TP53 is the most commonly mutated gene in cancer.…
The Food and Drug Administration (FDA) granted accelerated approval to selpercatinib for the following indications:…
Researchers from Penn State College of Medicine identified a new gene mutation that may cause…
Scientists have identified a gene mutation in the tumours of men with prostate cancer that…
A large-scale study provides new insights into the mechanisms that can lead to cancer. It…
A multi-institutional research team has identified what may be a novel mechanism underlying acquired resistance…